From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 80 Pages
India
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 80 Pages
France
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 80 Pages
China
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 350 Pages
Global
From €1092EUR$1,250USD£948GBP
€2183EUR$2,500USD£1,897GBP
- Report
- June 2023
- 182 Pages
Global
From €3144EUR$3,600USD£2,731GBP
- Report
- June 2023
- 76 Pages
North America
From €1310EUR$1,500USD£1,138GBP
- Report
- June 2025
- 128 Pages
Canada
From €5235EUR$5,995USD£4,548GBP
- Report
- June 2025
- 126 Pages
Australia
From €5235EUR$5,995USD£4,548GBP
- Report
- June 2025
- 123 Pages
India
From €5235EUR$5,995USD£4,548GBP
- Report
- June 2025
- 134 Pages
South Korea
From €5235EUR$5,995USD£4,548GBP
- Report
- June 2025
- 123 Pages
Italy
From €5235EUR$5,995USD£4,548GBP
- Report
- June 2025
- 126 Pages
Germany
From €5235EUR$5,995USD£4,548GBP
- Report
- June 2025
- 126 Pages
France
From €5235EUR$5,995USD£4,548GBP
- Report
- June 2025
- 122 Pages
United Kingdom
From €5235EUR$5,995USD£4,548GBP
- Report
- June 2023
- 35 Pages
Italy
From €3489EUR$3,995USD£3,031GBP
- Report
- June 2023
- 34 Pages
Germany
From €3489EUR$3,995USD£3,031GBP
- Report
- June 2023
- 36 Pages
Canada
From €3489EUR$3,995USD£3,031GBP
- Report
- June 2023
- 36 Pages
Australia
From €3489EUR$3,995USD£3,031GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more